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Abstract
Background: Minimally invasive autopsy by post mortem magnetic resonance (MR) imaging has been suggested
as an alternative for conventional autopsy in view of the declining consented autopsy rates. However, large
prospective studies rigorously evaluating the accuracy of such an approach are lacking. We intend to compare the
accuracy of a minimally invasive autopsy approach using post mortem MR imaging with that of conventional
autopsy in fetuses, newborns and children for detection of the major pathological abnormalities and/or
determination of the cause of death.
Methods/Design: We recruited 400 consecutive fetuses, newborns and children referred for conventional autopsy to
one of the two participating hospitals over a three-year period. We acquired whole body post mortem MR imaging
using a 1.5 T MR scanner (Avanto, Siemens Medical Solutions, Enlargen, Germany) prior to autopsy. The total scan time
varied between 90 to 120 minutes. Each MR image was reported by a team of four specialist radiologists (paediatric
neuroradiology, paediatric cardiology, paediatric chest & abdominal imaging and musculoskeletal imaging), blinded to
the autopsy data. Conventional autopsy was performed according to the guidelines set down by the Royal College of
Pathologists (UK) by experienced paediatric or perinatal pathologists, blinded to the MR data. The MR and autopsy data
were recorded using predefined categorical variables by an independent person.
Discussion: Using conventional post mortem as the gold standard comparator, the MR images will be assessed for
accuracy of the anatomical morphology, associated lesions, clinical usefulness of information and determination of
the cause of death. The sensitivities, specificities and predictive values of post mortem MR alone and MR imaging
along with other minimally invasive post mortem investigations will be presented for the final diagnosis, broad
diagnostic categories and for specific diagnosis of each system.
Clinical Trial Registration: NCT01417962
NIHR Portfolio Number: 6794
Keywords: Autopsy, post mortem magnetic resonance imaging, stillbirth, sudden infant death, diagnostic study,
minimally invasive autopsy
Background
For over 500 years a post mortem examination has been
used to establish cause of death. This procedure provides
valuable information on pathological processes - one of
the key foundations of medical education. Perinatal and
neonatal post mortem examination has a particularly
valuable role; this was formally recognised some 15 years
ago when the Royal College of Obstetricians and Gynae-
cologists (RCOG) and Royal College of Pathologists
recommended that a perinatal post mortem examination
rate of less than 75% was unacceptable and that the ideal
was 100% [1,2]. Autopsy rates have steadily declined over
the years since this document was published [2-5]. This
decline has been accelerated by adverse publicity sur-
rounding alleged organ retention without formal parental
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consent in the Bristol Royal Infirmary Inquiry [6] and the
Royal Liverpool Children’s Inquiry [7]. Neonatal post
mortem examination consent rate was less than 20% in
England and Wales in the most recent report of the Con-
fidential Enquiry into Stillbirths and Deaths in Infancy
(CESDI) [8].
The loss of a fetus, baby or child is devastating to par-
ents. As well as coping with their loss, parents often want
to know why their child died, and if there is an increased
risk for existing children or for future pregnancies. A
post mortem examination may provide this information.
In 14-46% of perinatal and infant post mortem examina-
tions, additional clinically significant information is
found beyond that known prior to the examination,
which would affect counselling or recurrence risks
[3,4,9,10]. The findings may confirm or refute clinical
diagnoses made during life. Many studies report signifi-
cant disagreement between the pre-morbid diagnosis and
post mortem examination in at least 10% of cases. This
impacts both upon recurrence risks and the approach to
prenatal diagnosis in future pregnancies [3,11]. Post mor-
tem examination thus has a valuable place in confirming
or refuting pre-morbid diagnoses, making further diag-
noses and identifying genetic and obstetric factors of
relevance to the management of future pregnancies,
allowing appropriate counselling of families who can
then make informed, reproductive choices. The post
mortem examination will also provide useful information
for clinicians, helping them to understand the causes and
effects of diseases as well as the effectiveness and compli-
cations of treatment. In addition, the post mortem exam-
ination can play a crucial role in research and so advance
the progress of fetal and paediatric medicine.
Should a post mortem examination be performed,
recent alterations to the post mortem examination proce-
dure and consent process may reduce the amount of infor-
mation available, especially for central nervous system
abnormalities [12-14]. Until recently, the usual practice
was to remove and fix the brain before dissection, a pro-
cess that could take up to 3 weeks. Parents now frequently
request that all organs are replaced before burial. As ade-
quate fixation is difficult within this time, the brain has to
be examined following a suboptimal period of fixation,
which can make interpretation of the developing brain dif-
ficult. Delay between intrauterine death and delivery, lead-
ing to maceration of the fetus, makes brain examination
more difficult for the pathologist. The RCOG guidelines
state that any pregnancy terminated after 22 weeks gesta-
tion should be accompanied by fetocide to ensure that the
fetus is not born alive. This procedure is usually accompa-
nied by the administration of mifepristone (a cervical
ripening drug), which has its optimum efficacy in shorten-
ing the time between induction and delivery after 48 hours
[15]. This effectively means that most delivered fetuses
undergoing termination of pregnancy after 22 weeks gesta-
tion will have been dead for at least 48 hours, rendering
post mortem examination of the brain difficult.
In addition to the difficulties of acquiring consent to
perform conventional autopsy, and sufficient time to per-
form optimal histological preparation, various religious
communities find conventional autopsy unacceptable [1].
Provision of a less invasive, accurate and widely available
method of post mortem assessment has been advocated
[1] and would enable access to post mortem information
for the first time for many in these communities.
In summary, a less invasive method of accurately
assessing detailed anatomical and pathological changes
in all body systems after death would be of great value.
Information for diagnosis and clinical audit can be
obtained as well as creating a permanent electronic
record of findings, whilst allaying parental concern with
regard to organ retention or conventional invasive post
mortems.
Though conventional radiology to assess the chest and
bones has been used for some time in post mortem
examination (for example, a skeletal survey is performed
on all paediatric cases referred to the coroner and in all
perinatal cases), MR imaging would be well suited as a
non-invasive imaging modality for post mortem assess-
ment. Standard imaging protocols could be performed
in any hospital equipped with an MR scanner and the
images sent to a centre of expertise for reporting. MR
imaging would potentially overcome some of the weak-
nesses of conventional autopsy, providing a complete
multisystem analysis that is non-invasive.
MR imaging of the excised brain [16], spine [17] and
heart [18] has been successfully performed. However,
although an initial feasibility study of whole-body post
mortem MR imaging was reported in 1996 [19], its use in
clinical practice has remained controversial. Several small
studies of whole-body post mortem MR in fetuses have
been reported [20-22]. In all fetal studies, imaging of the
central nervous system (CNS) proved the most accurate,
whilst body imaging, in particular imaging of the heart
proved more problematic. A recent study, focussed on
the diagnosis of CNS abnormalities in fetuses and still-
births, reported a sensitivity of 100% and specificity 92%
for MR compared with conventional post mortem exami-
nation [23]. Other studies have confirmed the accuracy
of CNS fetal post mortem MR [24,25]. Imaging of the
other body systems has been less well documented. Our
own recent experience is that accurate post mortem body
MR image acquisition is possible with modern MR ima-
ging sequences (unpublished data), but post mortem MR
imaging of the heart is less accurate [26-28].
Furthermore, MR imaging has grown in clinical
importance in the living fetus and newborn infant [29],
especially for brain anomalies. There is now extensive
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literature describing the normal MR imaging appearance
of the in utero fetal brain from around 17 weeks gesta-
tion [30] and the ex-utero preterm infant brain from
around 25 weeks gestation [31].
The decline in parental consent for autopsy, and
technical limitations of conventional autopsy to define
some nervous system abnormalities, together with a
reduction in number of skilled perinatal pathologists
and morphologists, has lead to a need to seek alterna-
tive less invasive methods for post mortem examina-
tion of the fetus, neonate and child. In 2001, the UK
Chief Medical Officer recommended that modern ima-
ging methods should be evaluated [32]. Since then sev-
eral reports on forensic aspects of post mortem
imaging have been published, however, these studies
are limited to post mortem imaging in adults, primarily
using computerised tomography (CT) and many studies
were of poor quality [33].
Our previously published systematic review on post
mortem MR imaging in fetuses, newborns, children
and adults demonstrates that there is insufficient evi-
dence to recommend the use of post mortem MR ima-
ging as an alternative for conventional autopsy [34].
Most comparative studies to date have been small and/
or have compared single systems such as the brain and
did not have adequate blinding of radiologists and
pathologists due to their retrospective nature. In parti-
cular, none have (a) systematically examined all the
body systems in a large series of fetal, neonatal and
childhood deaths (b) assessed the MR appearance of
death-induced artefacts or the effect that death and
maceration may have on the MR image (c) have
assessed the possible disadvantages or advantages of a
minimally invasive post mortem examination in combi-
nation with MR imaging.
Thus, over a decade after the first description of post
mortem MR imaging, we still lack the evidence for routine
implementation. Here we describe a large, prospective,
blinded, comparative study to evaluate MR as an alterna-
tive to conventional invasive autopsy in fetuses, newborns
and children.
Hypothesis
MR imaging can provide an accurate, detailed, three-
dimensional post mortem record of structural abnormal-
ities and the disease processes of the whole body in the
fetus, neonate and child, with similar diagnostic informa-
tion to a conventional autopsy.
Primary objective
To compare the accuracy of whole body post mortem
MR imaging for detecting the cause of death and/or
major pathological lesions with that of conventional
autopsy in fetuses, newborns and children.
Secondary objectives
To compare ante mortem imaging assessment (ultra-
sound and MR) of fetuses with post mortem MR and
CT images.
To compare ante mortem diagnosis, including imaging
data, in neonates, infants and children with post mortem
MR images.
Methods/Design
The study has been ongoing at two hospitals: Great
Ormond Street Hospital for Children NHS Trust (GOSH)
and University College Hospital NHS Foundation Trust
(UCH), since March 2007. These hospitals are associated
with a single academic institution - University College
London (UCL). All recruited cases underwent post mor-
tem MR imaging at 1.5 T (Avanto, Siemens Medical Solu-
tions, Enlargen, Germany) as well as a conventional
autopsy. CT imaging was also performed in cases with sus-
pected traumatic injury or skeletal dysplasia.
In line with the CESDI recommendations, post mortem
examination was offered in all cases of perinatal death and
consent sought by the appropriately trained staff (consul-
tant, experienced nurse, or experienced midwife). For con-
sented autopsies, the standard National Health Service
(NHS) consent form (produced by Department of Health)
that includes consenting for the use of post mortem ima-
ging for research was used (consent form and patient
information sheet given in appendix 1 and 2) [35,36].
In Her Majesty’s (HM) Coroner’s cases no parental con-
sent for autopsy was required and so, once the body was
received by the GOSH mortuary, a member of the
research team contacted the HM coroner’s office for per-
mission for a bereavement nurse to approach the parents
by telephone to gain consent for MR. If the parents gave
verbal consent, a pre-paid envelope with consent form and
information leaflet was sent to the parents (see reference
35 for full details of this process). Once MR consent was
obtained, a post mortem MR was performed prior to stan-
dard autopsy. Great Ormond Street Hospital and Institute
of Child Health Research Ethics Committee (04/Q0508/
41) approved the study.
Post mortem MR imaging
The first 20 subjects were used to optimise the imaging
sequences. These subjects will not be included in the
main study. The optimised MR study protocol is given in
Table 1. A team of four specialist radiologists (paediatric
neuroradiology, paediatric cardiology, paediatric chest &
abdominal imaging and musculoskeletal imaging) Each
reported the MR image, blinded to the autopsy report.
Each radiologist reported the post mortem MR indepen-
dently on to a large Microsoft access database (Microsoft
Inc, Redmond, USA), with predefined drop down menus
of categorical variables and codes (based on standard
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autopsy reporting). The MR data will be then re-classified
jointly by a radiologist and a pathologist with regards to
the likely final diagnosis, broad diagnostic categories and
specific abnormalities of each organ system.
Conventional autopsy
Experienced paediatric or perinatal pathologists performed
all autopsies according to the Royal College of Patholo-
gists’ guidelines, with input from specialist paediatric car-
diac pathologists or neuropathologists as required. The
pathology data were entered into the same database using
an independent access portal, blinded to the MR data. The
categorisation will be the same as for the MR imaging (i.e.
specific final diagnosis, broad diagnosis category and sepa-
rate system normal/abnormal rating) (Table 2). This pro-
vides the gold standard against which the MR imaging is
assessed.
Data analysis
Using conventional post mortem as the gold standard
comparator, the MR images will be assessed for accuracy
of the anatomical morphology, associated lesions, clinical
usefulness of information and determination of the cause
of death. The primary outcome will be the percentage of
cases for which MR imaging correctly identifies the diag-
nostic category. Secondary analyses will make more
detailed comparison of the individual measurements
recorded within both autopsy types to facilitate under-
standing of how different diagnoses may occur. The sen-
sitivities, specificities and predictive values of: (i) MR
imaging plus clinical history, and (ii) MR imaging plus
clinical history and other non-invasive post mortem
investigations (e.g. external examination, genotyping, pla-
cental examination and skeletal survey) and to identify:
(a) the specific diagnosis (b) one of predefined broad
categories of diagnosis and (c) specific diagnostic cate-
gory for each system, will be presented.
Changes according to weight of the fetus/infant/child
will be investigated using logistic regression models.
Diagnostic statistics will also be presented for the indivi-
dual components (brain, chest, abdomen, heart and
musculoskeletal) to determine areas of good and bad
concordance. All estimates will be presented with 95%
confidence intervals. Ante mortem assessments will be
similarly compared with those made post mortem.
Sample size calculations
To determine the primary outcome of percentages cor-
rectly diagnosed to within +/- 5% with 95% confidence
will require 400 cases if the percentage correct is as low
as 50%. We anticipate that the percentage correct will be
substantially higher than this, in which case the estimate
will be more precise. If the percentage correct is as high
as 90%, then this will be estimated to within +/- 3% with
a sample of 400.
Similarly for the individual components, we anticipate a
wide range in the age distribution of cases and this should
allow some quantification of changes by weight. Further
investigations within specific diagnoses will necessarily be
based on smaller numbers and are hence more exploratory
Table 1 Sequences for post mortem magnetic resonance imaging
Sequence Voxel size TA (min) TR (ms) TE (ms) Flip angle0 Averages
BRAIN IMAGING
3 D CISS 0.6 × 0.6 × .06 mm 13.5 9.2 4.6 70 4
3D Flash T1W 1 × 1 × 1 mm 5.4 11 4.9 15 3
2D Destir T2W 0.4 × 0.4 × 0.4 mm 13.5 5460 14,115 150 6
GE (Haem) 0.5 × 0.4 × 4 mm 6.3 800 26 20 4
DWI B = 0, b = 500, b = 1000
SPINE IMAGING
2D T2-W TSE (children only) 1 × 1 × 3 mm 5.43 3050 109 170 3
3D CISS
(fetus only)
0.6 × 0.6 × 1 mm 4.2 9.1 4.5 70 8
3D T1-W Flash 0.6 × 0.6 × 1 mm 3.5 11 5.3 15 10
BODY IMAGING
T2 W TSE 0.8 × 0.8 × 0.8 mm 6.2 3500 276 2
3D CISS 0.8 × 0.8 × 0.8 mm 5.2 5.2 2.3 54 3
3D T1W VIBE 0.8 × 0.8 × 0.8 mm 5.5 5.9 2.4 25 8
3D CISS (cardiac) 0.6 × 0.6 × 0.6 mm 29 5.6 2.5 54 10
TA: Time for acquisition, TR: Relaxation time, TE: Echo time, ms: milli second, min: minutes
CISS: Constructive Interference Steady State, GE: Gradiant Echo, TSE: Turbo spin echo, DWI: Diffusion weighted imaging
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Table 2 Specific diagnostic categories
Code Diagnosis
1 Normal
2 Abnormal
3 Non Diagnostic
4 Not confirmed
5 Not examined
6 Unexplained
7.01 Abdomen Abdominal wall defect
7.02 Abdomen Acute Intra abdominal pathology
7.03 Abdomen Adrenal haemorrhage
7.04 Abdomen Cloacal extrophy
7.05 Abdomen Dilated gut
7.06 Abdomen Duodenal atresia
7.07 Abdomen Exompholos
7.08 Abdomen Gastroenteritis
7.09 Abdomen Gastroschisis
7.1 Abdomen Gut infarction
7.11 Abdomen Hepatic necrosis
7.12 Abdomen Hepatomegaly
7.13 Abdomen Intestinal atresia
7.14 Abdomen Intestinal obstruction
7.15 Abdomen Large kidneys
7.16 Abdomen Liver artefacts
7.17 Abdomen Liver haemangioma
7.18 Abdomen Malrotation
7.19 Abdomen Meckel’s Diverticulum
7.2 Abdomen Necrotising enterocolitis
7.21 Abdomen No spleen
7.22 Abdomen Peri-portal abnormality
7.23 Abdomen Rectal obstruction
7.24 Abdomen Small adrenals
7.25 Abdomen Splenomegaly
7.26 Abdomen Strangulated hernia
7.27 Abdomen Subcapsular haematoma
7.28 Abdomen Traumatic abdominal wall defect
7.29 Abdomen Volvulus/malrotation
7.3 Abdomen Other
8.01 Brain Acquired brain damage
8.02 Brain Aqueductal stenosis
8.03 Brain Bilateral thalamic damage/haemorrhage
8.04 Brain Brain malformation non specified
8.05 Brain Brain stem encephalitis
8.06 Brain Callosal agenesis
8.07 Brain Cap Haemangioma/Leukoencephalopathy
8.08 Brain Cerebellar abnormality
8.09 Brain Cerebellar fossa cyst
8.1 Brain Cerebellitis
8.11 Brain Cerebral infarction
Table 2 Specific diagnostic categories (Continued)
8.12 Brain Chronic Brain Injury
8.13 Brain Complex neuropathological changes
8.14 Brain Congenital brain malformation
8.15 Brain Congenital brain malformation-Specific diagnosis
8.16 Brain Cortical maldevelopment
8.17 Brain Cranial vascular Malformation
8.18 Brain Dandy walker syndrome/variant
8.19 Brain Destructive brain lesion
8.2 Brain Diffuse brain injury
8.21 Brain Dural sinus malformation
8.22 Brain Globus pallidus abnormal
8.23 Brain Head Injury
8.24 Brain Infective brain lesion
8.25 Brain Inter-hemispheric Arachnoid cyst
8.26 Brain Intracranial bleed
8.27 Brain Ischemic brain injury
8.28 Brain Lissencephaly
8.29 Brain Microcephaly
8.3 Brain Microlissencephaly
8.31 Brain Neurological abnormality NOS
8.32 Brain Non-obstructive hydrocephalus
8.33 Brain Neural tube defect
8.34 Brain Old brain injury
8.35 Brain Polymicrogyria
8.36 Brain Pontine calcification
8.37 Brain Porencephaly
8.38 Brain Preterm brain injury
8.39 Brain Ruptured cerebral aneurysm
8.4 Brain Schizencephaly
8.41 Brain Schizencephaly/Septo optic dysplasia
8.42 Brain Subdural bleed
8.43 Brain Small cerebellum
8.44 Brain Spinal dysraphism
8.45 Brain Spinal intrathecal haemorrhage
8.46 Brain Tentorial tear
8.47 Brain Thalamic bleed
8.48 Brain Ventriculomegaly
8.49 Brain Vermis hypoplasia
8.5 Brain White matter lesions
8.51 Brain Other
9.01 Chest Aspiration
9.02 Chest Chronic lung disease
9.03 Chest Cytomegalovirus pneumonitis
9.04 Chest Congenital diaphragmatic hernia
9.05 Chest Congenital neck malformation
9.06 Chest Consolidation
9.07 Chest Cystic hygroma
9.08 Chest Drowning
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Table 2 Specific diagnostic categories (Continued)
9.09 Chest Hyaline membrane disease
9.1 Chest Lung lesion
9.11 Chest Meconium aspiration
9.12 Chest Pneumonia
9.13 Chest Pneumonia/Specific virus
9.14 Chest Pulmonary congestion and edema
9.15 Chest Pulmonary haemorrhage
9.16 Chest Pulmonary hypertension
9.17 Chest Small lungs/Hypoplasia
9.18 Chest Sub glottic stenosis
9.19 Chest Tracheo oesophageal fistula
10.01 Genetic Body stalk anomaly
10.02 Genetic Chromosomal abnormality
10.03 Genetic Other mutations
10.04 Genetic Genetic Syndrome
10.05 Genetic Other
10.06 Genetic Larson-like syndrome
10.07 Genetic Miller Dieker syndrome
10.08 Genetic Palister-Hall syndrome
10.09 Genetic Pallister-killian syndrome
10.1 Genetic Sirenomelia
10.11 Genetic TRAP
10.12 Genetic Trisomy 18
10.13 Genetic Trisomy 21
10.14 Genetic Turner’s syndrome
11.01 Haematology Congenital leukaemia
11.02 Haematology Fetal anaemia/Parvo virus
11.03 Haematology Fetomaternal bleed
11.04 Haematology Haematological
11.05 Haematology Myelodysplastic syndrome
11.06 Haematology Rhesus isoimmunisation
12.01 Heart Aortic Valvular stenosis
12.02 Heart Cardiac ion channelopathy
12.03 Heart Atrial septal defect
12.04 Heart Atrioventricular septal defect
12.05 Heart Bi ventricular hypertrophy
12.06 Heart Blocked cardiac shunt
12.07 Heart Cardiac abnormality
12.08 Heart Cardiac Teratoma
12.09 Heart Cardiac Tumor
12.1 Heart Cardiomegaly
12.11 Heart Cardiomyopathy
12.12 Heart Coarctation
12.13 Heart Common arterial trunk
12.14 Heart Complex Congenital heart disease
12.15 Heart Congenital heart disease non specified
12.16 Heart Cortriatrum
Table 2 Specific diagnostic categories (Continued)
12.17 Heart Dextrocardia
12.18 Heart Dilated cardiomyopathy
12.19 Heart Double outlet right ventricle
12.2 Heart Hypoplastic left heart syndrome
12.21 Heart Left atrial isomerism
12.22 Heart Myocardial infarction
12.23 Heart Myocarditis
12.24 Heart Narrowed cardiac shunt
12.25 Heart Pulmonary atresia
12.26 Heart Persistent left superior vena cava
12.27 Heart Restrictive foramen ovale
12.28 Heart Retro oesophageal right subclavian
12.29 Heart Right isomerism
12.3 Heart Partial anomalous venous drainage
12.31 Heart Situs inversus
12.32 Heart Situs inversus/Congenital heart disease
12.33 Heart Total anomalous venous drainage
12.34 Heart Tetrology of Fallot
12.35 Heart Transposition of great arteries
12.36 Heart Tricuspid Atresia
12.37 Heart Ventricular septal defect
12.38 Heart Ventricular septal defect/Coarctation
13.01 Metabolic specific metabolic diagnosis
13.02 Metabolic Steatosis/Non specific Metabolic diagnosis
14.01 Musculoskeletal Arthrogyposis
14.02 Musculoskeletal Cleft palate
14.03 Musculoskeletal Cleft vertebrae
14.04 Musculoskeletal Congenital myasthenia gravis
14.05 Musculoskeletal Fracture skull
14.06 Musculoskeletal Fracture long bones
14.07 Musculoskeletal Lacerated muscle
14.08 Musculoskeletal Other
14.09 Musculoskeletal Osteogenesis imperfecta
14.1 Musculoskeletal Osteogenesis imperfecta type II
14.11 Musculoskeletal Osteogenesis imperfecta type IIa
14.12 Musculoskeletal Osteogenesis imperfecta type IIb
14.13 Musculoskeletal Myopathy
14.14 Musculoskeletal Rib fractures
14.15 Musculoskeletal Shoulder dystocia
14.16 Musculoskeletal Skeletal dysplasia
14.17 Musculoskeletal Short limb dysplasia non specific
14.18 Musculoskeletal Talipes
14.19 Musculoskeletal Thanatophoric dysplasia
14.2 Musculoskeletal Thanatophoric dysplasia like
osteochondrodysplasia
14.21 Musculoskeletal Thanatophoric dysplasia type 1
15.01 Other Hydrops
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than definitive in nature. Presentation with confidence
intervals will indicate any under-powering of the
comparisons.
Discussion
Over the past decade, the consent rate for autopsy in
the newborn has been less than 20% in the UK [8];
pediatric autopsies have become virtually non-existent,
apart from the cases investigated by the HM Coroners
or police (forensic cases), where parental consent is not
required. Furthermore, this decline has occurred despite
an increase in the number of cases in which autopsy
consent (approximately 80% of cases following a perina-
tal death) is sought by the clinicians. One of the key rea-
sons for parental refusal is the apparent invasive nature
of conventional autopsy.
Although post mortem MR imaging was reported as
an alternative for conventional autopsy more than a
decade ago, it has not been introduced into routine
clinical practice as supporting evidence is based on
small and poorly designed studies [35]. In the UK, its
use has been limited to some private initiatives. The
Chief Medical Officer (UK) recommended rigorous
evaluation of post mortem MR imaging as an alterna-
tive for autopsy, before it is widely introduced into the
UK clinical practice. Following this, the UK Depart-
ment of Health funded the present study (MaRIAS-
Magnetic Resonance Imaging Autopsy Study) for sys-
tematic and rigorous evaluation of post mortem MR
imaging as an alternative for conventional autopsy
with a view to making recommendations to the
Department of Health with regard to the advisability of
introduction into routine clinical practice, either on its
own or along with other minimally invasive post mor-
tem investigations [37].
Quality assurance of the data
Transparent Research Audit System (TRUST) guidelines
will be followed for analysis, authorships and publication
of the MaRIAS data. AMT re-examined all MR images
and cross checked against the radiology reports on all
organ systems for quality assurance. Shea Addison (SA)
will cross check all the pathology data for any data entry
errors. AMT, NJS and SA will be responsible for clean-
ing the data. The final data used for analysis and accu-
rate contributions of each author will be stored at UCL
until 2032 for research data auditing. ST and AMT will
be the custodians of the MaRIAS data. All manuscripts
from the study will be reviewed by the Department of
Health (UK), ST and AMT before submission, though
the Department of Health (UK) does not influence the
scientific content of any research output.
Table 2 Specific diagnostic categories (Continued)
15.02 Other Ichthyosis
15.03 Other Intrauterine growth retardation
15.04 Other multi organ failure
15.05 Other Prematurity
15.06 Other Surgical emphysema
16.01 Placenta Other
16.02 Placenta Chorioamnionitis/Funisitis
16.03 Placenta Cord prolapse
16.04 Placenta Fetal thrombotic vasculopathy
16.05 Placenta Histiocytic intervillositis
16.06 Placenta Infarction
16.07 Placenta Placental abruption
16.08 Placenta Placental pathology-Infective
16.09 Placenta Placental pathology-Non Infective
16.1 Placenta Prolonged rupture of membranes
16.11 Placenta Spontaneous rupture of membranes
16.12 Placenta Utero placental disease
16.13 Placenta Villitis of Unknown aetiology
17.01 Renal Bladder outlet obstruction
17.02 Renal Congenital renal malformation
17.03 Renal Cystic kidney disease
17.04 Renal Focal renal dysplasia
17.05 Renal Focal renal non specified
17.06 Renal Large kidneys
17.07 Renal Obstructive uropathy
17.08 Renal Renal adysplasia
17.09 Renal Renal agenesis
17.1 Renal Renal developmental abnormality
17.11 Renal Renal dysplasia
17.12 Renal Renal tubular necrosis
17.13 Renal Syndromic Cystic Renal Dysplasia
18.01 Sepsis Cytomegalovirus
18.02 Sepsis Adeno virus infection
18.03 Sepsis Herpes simplex virus
18.04 Sepsis Intra uterine infection: Non specified
18.05 Sepsis Sepsis
18.06 Sepsis Sepsis/E coli
18.07 Sepsis Sepsis/Group B Streptococci
18.08 Sepsis Other Streptococcal infection
18.09 Sepsis Toxoplasmosis
18.1 Sepsis Cytomegalovirus
19.01 Trauma Hanging
19.02 Trauma Non accidental injury
19.03 Trauma Traumatic other
20.01 Tumor Sacro coccygeal teratoma
20.02 Tumor Other tumors
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Appendix 1: Information leaflet
VERSION 1.0
28.4.2007
xxxxxxxx
Post mortem Magnetic Resonance Imaging in
fetuses, newborn and Children: A comparative study
with conventional autopsy.
Information leaflet for parents
Thank you for taking the time to read this leaflet. We
know that this is a difficult time for you and appreciate
the time you are taking to read this leaflet.
Background to the study
MRI (Magnetic resonance imaging) and CT scans, as
you may be aware are special techniques to get images of
the body. An MRI scan can examine internal organs in
detail and may be able to identify some of the problems
that can be detected by a post mortem examination. In
some cases, we believe that MRI may even be better than
a post mortem examination. Many parents are under-
standably upset about the thought of their baby under-
going a post mortem. We are doing this study to find out
if an MRI scan of the whole body can give similar informa-
tion to that of post mortem, so that in future we might be
able to offer an MRI scan instead of post mortem.
What will happen if we agree to take part?
If you agree to take part we will arrange for your baby to
have an MRI scan (and in some cases a CT scan as well)
as soon as possible at Great Ormond Street Hospital for
Children. This involves taking a series of pictures using a
special machine. We may take biopsy using small needles
under MRI guidance, for examination under microscope.
The whole process will take about 2 hours. As soon as the
scan is done we will arrange for your baby to be taken for
the traditional post mortem. We will ensure that at all
times your baby will be treated with due respect and
reverence.
The MRI scan will not delay the post mortem or the
timing of burial or cremation. Taking part would not
involve you in any extra hospital visits. Any additional
information, if any from MRI/CT scan will be included in
autopsy report to the coroner. We will also need to have
access to the post mortem results and the results of any
other tests that were done before or after birth. This is so
that we can compare the results of tests which are done
traditionally with the results from the MRI and work out
which combination of tests give the most accurate results
overall.
Will my taking part in this study be kept
confidential?
All information that is collected about you or you
baby or during the course of the research will be kept
strictly confidential. Any information we collect will
only be used by the research team for the purpose of
the study.
Who will have access to the case/research records?
All the data and images collected as part of this study
will be stored on a secure computer. Only the researchers
involved in this study will have access to the data col-
lected in the course of this study. A representative of the
hospital’s Research Ethics Committee will also have
access to data. The 1988 Data Protection Act safeguards
the use of some types of personal information. This
places an obligation on those who record or use personal
information, but also gives rights to people about whom
information is held. If you have any questions about data
protection, please contact the Data Protection officer via
the switchboard on 0845 155 5000. The results from our
project will be published as papers in medical journals.
No data will be published that allows for individuals to
be identified in any way. If requested, we will be able to
send you copies of any papers published when we have
completed the study in 3-4 years time.
Do you have to take part?
It is up to you to decide whether or not to take part.
If you do decide to take part you will be given this
information sheet to keep and will be asked to sign a
consent form. You will be given a copy of the signed
consent form for your records. If you do not feel able to
take part it will not in any way affect the care your
family receives.
Who do I speak to if I have further questions or
worries?
In the first instance please contact xxx who is coordi-
nating this project. His contact details are given below.
xxx can also be contacted if you need any further infor-
mation or xxx is not available. If you wish to speak to
someone not directly involved in the study then please
contact xxxxx
If you have any complaints about the way in which
the project is being or has been conducted, in the first
instance please discuss them with any of the doctors
listed below. If the problems are not resolved, or you
wish to comment in any other way please contact xxxx
Who is organising and funding the research?
This study is being organised by the Cardiothoracic,
Radiology and Pathology Departments at Great Ormond
Street Hospital for Children and by the Fetal and Neo-
natal Medicine Units and Pathology Department at Uni-
versity College London Hospital, Funding is provided by
the Department of Health. This study has been reviewed
and approved by the Great Ormond Street Hospital
Research Ethics Committee.
Thank you once again for all your time and trouble.
Contacts for further information: XXXX
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Appendix 2: Consent form
Version 1.0
REC reference number: 04/Q0508/41
Study R & D Number: 04CC20
Patient Name....................
Unit Number....................
Date of Birth....................
Patient Identification Number for this trial:.................
CONSENT FORM
Title of Project: Post mortem magnetic resonance
imaging in the fetus, infant and child: A comparative
study with conventional autopsy
1. I confirm that I have read and understand the infor-
mation sheet dated 28/9/07 (version 1.0) for the above
study, and have had the opportunity to ask any ques-
tions. ☐
2. I understand that my participation is voluntary, and
that I am free to withdraw at any time, without giving
any reason, without my medical care or legal rights
being affected. ☐
3. I understand that sections of baby’s medical notes
may be looked at by responsible individuals named in
the study or by from regulatory authorities from the
Trusts. I give permission for these individuals to have
access to baby’s records. ☐
4. I agree to take part in the above study.
________________________ ____ ________________
Name of Parent/Legal Guardian Date Signature
____________________________________________
__ ____ _____________
Name of Person taking consent (if different from
Researcher) Date Signature
_________ ____ ________________
Researcher Date Signature
1 for Patient; 1 for Researcher; 1 to be kept with Hos-
pital Notes
List of Abbreviations
CESDI: Confidential Enquiry into Stillbirths and Deaths in Infancy; CISS:
Constructive Interference Steady State; DWI: Diffusion weighted imaging; GE:
Gradiant Echo; GOSH: Great Ormond Street Hospital for Children NHS Trust;
HM Coroner: Her Majesty’s Coroner; MR: Magnetic resonance; PROM:
Prolonged rupture of membranes; RCOG: Royal College of Obstetricians and
Gynaecologists; TA: Time for acquisition; TE: Echo time; TR: Relaxation time;
TSE: Turbo spin echo; UCH: University College Hospital Foundation NHS
Trust; UCL: University College London.
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